SPEAKERS Abbas Walji Senior Director, Discovery Chemistry Merck Adrian Whitty Associate Professor of Chemistry Boston University Andy Yan Director of Business Development - Eastern Region CPC Scientific Inc Cameron Pye Chief Executive Officer Unnatural Products Christian Cunningham Chief Scientific Officer PeptiDream Inc. David Brayden Full Professor, Advanced Drug Delivery University College Dublin David Diller Executive Director of Computation & AI Perpetual Medicines Dehua Pei Professor Ohio State University James Bowman Director of Protein Engineering AI Proteins Jeffrey Schubert Principal Scientist Merck Joshua Schwochert Co-founder & Chief Scientific Officer Unnatural Products Laura Nevola CSO IDP Pharma Manuel Sanchez-Felix Vice President - Drug Delivery Search & Evaluation Halozyme Therapeutics Markus Haeberlein EVP Parabilis Medicines Matthew Streeter Senior Scientist Entrada Therapeutics Inc. Meritxell Teixido Tura Ceo Gate2Brain S.L. Miriam Kidron Chief Scientific Officer & Director Oramed Pharmaceuticals Patrick Salveson Co-founder & Chief Technology Officer Vilya Pete Gough Chief Scientific Officer Nimble Therapeutics Ranganath gopalakrishnan Director AstraZeneca Rick Ewing Vice President, Head of Chemistry Rapafusyn Pharmaceuticals Sevan Habeshian Vice President, Platform Chemistry Orbis Medicines Thomas Von Erlach Co-Founder & Chief Scientific Officer Vivtex Tina Boville Co-founder & Chief Executive Officer Aralez Bio Toby Passioura Co-Founder & Chief Scientific Officer Insamo Biotech Tomi Sawyer Chief Drug Hunter & President Maestro Therapeutics Xavier Michelet Director AI Proteins Yoshihisa Murata Head of Advanced Computational Chemistry Group Chugai Pharmaceutical Co Yu-Shan Lin Professor and Department Chair of Chemistry Tufts University